- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We’re Reading: Health Insurance Rebates; More States Legalize Fentanyl Test Strips; Reanimated Hearts Used for Transplants
The possibility of individual Americans receiving a health insurance rebate is slim; more states are legalizing fentanyl test strips to fight soaring opioid deaths; reanimated hearts donated after death work just as well for transplants, study finds.
Possible Windfall in Health Insurance Rebates
Former Democratic Senator Al Franken recently posted on Twitter that Americans will receive “$1.1 B in rebates from health insurance companies this year” because of a provision he wrote into the Affordable Care Act, according to KFF Health News. While there will likely be rebates in 2023, most likely along the lines of $1.1 billion, the chance that these rebates will go directly to individuals is quite small. The provision, known as the medical loss ratio, refers to how much insurers spend on medical care for their enrollees vs other administrative costs and aims to curb those costs.
More States Legalizing Fentanyl Test Strips to Fight Opioid Deaths
Legalizing fentanyl test strips could bring the number of overdose deaths connected to the drug down, say advocates, by helping more people understand the possible lethality of their drugs, reported the Associated Press. Until this spring, test strip use was technically illegal in Ohio, which has now joined at least 20 other states whose lawmakers officially decriminalized the strips since Rhode Island became the first in 2018. Pennsylvania, South Dakota, Kentucky, and Mississippi also jumped on the bandwagon. The CDC recommends fentanyl test strips as a low-cost way of helping prevent drug overdoses.
Reanimated Hearts Donated Postmortem Work For Transplants, Study Finds
A new study found that an innovative method of heart transplantation that uses machines to reanimate donor hearts from people who have died after circulatory death is just as effective as traditional heart transplantation, according to STAT. If widely used in the US, the procedure could increase the donor pool by 30%. The adjusted 6-month survival rate of patients undergoing the new technique was 94%, compared with 90% among patients who underwent the traditional method using hearts from brain-death donors, according to the study published Wednesday.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
